Market revenue in 2023 | USD 140.7 million |
Market revenue in 2030 | USD 326.2 million |
Growth rate | 12.8% (CAGR from 2023 to 2030) |
Largest segment | Laboratory testing |
Fastest growing segment | Laboratory Testing |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Laboratory Testing |
Key market players worldwide | Alcami, Merck KGaA, Eurofins Scientific SE, Agilent Technologies Inc, Charles River Laboratories International Inc, Catalent Inc, Avomeen Analytical Services, Pace Analytical Services, Sotera Health Co Ordinary Shares |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceuticals manufacturing consumables testing market will help companies and investors design strategic landscapes.
Laboratory testing was the largest segment with a revenue share of 100% in 2024. Horizon Databook has segmented the Asia Pacific biopharmaceuticals manufacturing consumables testing market based on laboratory testing covering the revenue growth of each sub-segment from 2018 to 2030.
In the recent years, Asia Pacific has gained significant share in the global biopharmaceutical market, which has resulted in the fast growth of biopharmaceuticals production consumables testing. In the current years, this region has witnessed significant increase in biopharmaceutical R&D activities.
Due to low operational and manufacturing costs in Asian countries, like India and China, a number of global companies are outsourcing their R&D operations to this region. However, most of the API manufacturing is still restricted to the U.S., hence the U.S. business continues to outpace the Asia Pacific region.
Increase in R&D activities in the region, rise in investments on healthcare, entry of global market players, and constantly improving GDP are some of key factors contributing to the lucrative CAGR of this region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific biopharmaceuticals manufacturing consumables testing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific biopharmaceuticals manufacturing consumables testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account